RT Journal Article
SR Electronic
T1 Pharmacologic manipulation of complement receptor 3 prevents dendritic spine loss and cognitive impairment after acute cranial radiation
JF bioRxiv
FD Cold Spring Harbor Laboratory
SP 2020.11.25.398701
DO 10.1101/2020.11.25.398701
A1 Joshua J. Hinkle
A1 John A. Olschowka
A1 Jacqueline P. Williams
A1 M. Kerry O’Banion
YR 2020
UL http://biorxiv.org/content/early/2020/11/27/2020.11.25.398701.abstract
AB Cranial irradiation induces healthy tissue damage that can lead to neurocognitive complications and negatively impact patient quality of life. One type of damage associated with cognitive impairment is loss of neuronal spine density. Based on developmental and disease studies implicating microglia and complement in dendritic spine loss, we hypothesized that irradiation-mediated spine loss is microglial complement receptor 3 (CR3)-dependent, and associated with late-delayed cognitive deficits. Utilizing a model of cranial irradiation (acute, 10 Gy gamma) in C57BL/6 mice we found that male mice demonstrate irradiation-mediated spine loss and cognitive deficits whereas female mice and CR3 knockout mice do not. Moreover, pharmacological blockade of CR3 with leukadherin-1 (LA1) prevented these changes in irradiated male mice. Interestingly, CR3 KO mice showed reduced behavioral task performance suggesting that CR3 is important for normal learning and memory. Improving our understanding of irradiation-mediated mechanisms and sexual dimorphic responses is essential for the identification of novel therapeutics to reduce irradiation-induced cognitive decline and improve patient quality of life.Competing Interest StatementThe authors have declared no competing interest.